Immunovant Inc. Common Stock vs Lattice Semiconductor Corporation Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.25 (market cap $6.25B), while Lattice Semiconductor Corporation Common Stock trades at $127.91 (market cap $17.76B). The key difference: Lattice Semiconductor Corporation Common Stock is far larger — about 2.8× Immunovant Inc. Common Stock's market cap, and Lattice Semiconductor Corporation Common Stock is trading nearer its 52-week high, Immunovant Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Lattice Semiconductor Corporation Common Stock for 0 Days on average.
| IMVT | LSCC | |
|---|---|---|
Market Cap | $6.25B | $17.76B |
Volume | 1,755,411 | 1,802,283 |
Sector | Health | Technology |
52-Week High | $44.96 | $155.27 |
52-Week Low | $17.03 | $61.73 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.35B | $17.62B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →Lattice Semiconductor develops low-power programmable chips, known as FPGAs. Its products are used in communications, computing, industrial, and automotive applications.
Read more on LSCC →